文献

J-GLOBAL ID：201902200823794655   整理番号：19S0743598

IDH1 mutation as a potential novel biomarker for distinguishing pseudoprogression from true progression in patients with glioblastoma treated with temozolomide and radiotherapy

著者 (8件)： Motegi, Hiroaki (Department of Neurosurgery, Graduate School of Medicine, Hokkaido University) ,  Kamoshima, Yuuta (Department of Neurosurgery, Graduate School of Medicine, Hokkaido University) ,  Terasaka, Shunsuke (Department of Neurosurgery, Graduate School of Medicine, Hokkaido University) ,  Kobayashi, Hiroyuki (Department of Neurosurgery, Graduate School of Medicine, Hokkaido University) ,  Yamaguchi, Shigeru (Department of Neurosurgery, Graduate School of Medicine, Hokkaido University) ,  Houkin, Kiyohiro (Department of Neurosurgery, Graduate School of Medicine, Hokkaido University) ,  Tanino, Mishie (Department of Pathology, Graduate School of Medicine, Hokkaido University) ,  Murata, Junichi (Sapporo Asabu Neurosurgical Hospital)
資料名： Brain Tumor Pathology
巻： 30  号： 2  ページ： 67-72  発行年： 2013年 
JST資料番号： SCOPUS  ISSN： 1433-7398  CODEN： BTPAF 
発行国： 日本 (JPN)  言語： 英語 (EN)

タイトルに関連する用語 (1件)： IDH1